Results were recently published in a study in  the Journal of Clinical Microbiology that show  limitations of currently available diagnostic tests for early-stage Lyme disease, and highlight the need for more research toward improved diagnostics and treatments. 

Joining me today to discuss the study and the findings is Liz Horn, PhD. Dr Horn is the Principal Investigator with the Lyme Disease Biobank.

Show notes: 

The Lyme Disease Biobank – Characterization of 550 Patient and Control Samples from the East Coast and Upper Midwest of the United States

Lyme Disease Biobank

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | RSS

Hand Soaps & Sanitizers at Dollar Tree!

Related:

Lyme disease in the US: The Quest Diagnostics Health Trends report

One Health with Cheryl Stroud, DVM, PhD

Lyme disease: The major players, the disagreements and the IDSA draft guidelines

Lyme testing with Monica Embers, PhD

Lyme disease: New study confirms dogs are sentinels to assess human risk

Lyme ‘persister’ bacteria and a three-antibiotic cocktail: A study


Lyme disease, ticks and the ecology with Richard Ostfeld, PhD

Asian longhorned ticks with Maria Diuk-Wasser, PhD

Chikungunya and Lyme vaccine candidates with Valneva CEO Thomas Lingelbach

Lyme disease, the Federal Tick-borne Disease Working Group and an IDSA letter with Timothy Sellati, PhD